Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis
Open Access
- 22 December 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 32 (17), 2168-2178
- https://doi.org/10.1093/eurheartj/ehq467
Abstract
Coxsackievirus B3 (CVB3)-induced myocarditis, initially considered a sole immune-mediated disease, also results from a direct CVB3-mediated injury of the cardiomyocytes. Mesenchymal stem cells (MSCs) have, besides immunomodulatory, also anti-apoptotic features. In view of clinical translation, we first analysed whether MSCs can be infected by CVB3. Next, we explored whether and how MSCs could reduce the direct CVB3-mediated cardiomyocyte injury and viral progeny release, in vitro, in the absence of immune cells. Finally, we investigated whether MSC application could improve murine acute CVB3-induced myocarditis. Phase contrast pictures and MTS viability assay demonstrated that MSCs did not suffer from CVB3 infection 4–12–24–48 h after CVB3 infection. Coxsackievirus B3 RNA copy number decreased in this time frame, suggesting that no CVB3 replication took place. Co-culture of MSCs with CVB3-infected HL-1 cardiomyocytes resulted in a reduction of CVB3-induced HL-1 apoptosis, oxidative stress, intracellular viral particle production, and viral progeny release in a nitric oxide (NO)-dependent manner. Moreover, MSCs required priming via interferon-γ (IFN-γ) to exert their protective effects. In vivo, MSC application improved the contractility and relaxation parameters in CVB3-induced myocarditis, which was paralleled with a reduction in cardiac apoptosis, cardiomyocyte damage, left ventricular tumour necrosis factor-α mRNA expression, and cardiac mononuclear cell activation. Mesenchymal stem cells reduced the CVB3-induced CD4− and CD8− T cell activation in an NO-dependent way and required IFN-γ priming. We conclude that MSCs improve murine acute CVB3-induced myocarditis via their anti-apoptotic and immunomodulatory properties, which occur in an NO-dependent manner and require priming via IFN-γ.Keywords
This publication has 43 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJournal of the American College of Cardiology, 2009
- Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25Experimental Cell Research, 2009
- Interferon-γ and NF-κB mediate nitric oxide production by mesenchymal stromal cellsBiochemical and Biophysical Research Communications, 2007
- Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftmentBiochemical and Biophysical Research Communications, 2007
- TNF-α-mediated cardiomyocyte apoptosis involves caspase-12 and calpainBiochemical and Biophysical Research Communications, 2006
- Adenovirus Vector-Mediated Gene Transfer into Stem CellsMolecular Pharmaceutics, 2006
- Stress-Activated Protein Kinases Are Involved in Coxsackievirus B3 Viral Progeny ReleaseJournal of Virology, 2005
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2005
- Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome PathwayJournal of Virology, 2005
- Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected miceMedical Microbiology and Immunology, 2003